Your browser doesn't support javascript.
loading
Radiotherapy, tumor mutational burden, and immune checkpoint inhibitors: time to do the math.
Giordano, Frank A; Veldwijk, Marlon R; Herskind, Carsten; Wenz, Frederik.
Affiliation
  • Giordano FA; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany. frank.giordano@umm.de.
  • Veldwijk MR; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
  • Herskind C; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
  • Wenz F; Department of Radiation Oncology, University Medical Center Mannheim, Medical Faculty Mannheim, University of Heidelberg, Theodor-Kutzer-Ufer 1-3, 68167, Mannheim, Germany.
Strahlenther Onkol ; 194(10): 873-875, 2018 10.
Article in En | MEDLINE | ID: mdl-30030581

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Burden / Mutation Limits: Humans Language: En Journal: Strahlenther Onkol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2018 Document type: Article Affiliation country: Country of publication:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Tumor Burden / Mutation Limits: Humans Language: En Journal: Strahlenther Onkol Journal subject: NEOPLASIAS / RADIOTERAPIA Year: 2018 Document type: Article Affiliation country: Country of publication: